Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas E Kamen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemistry|April 3, 2002
Folding kinetics of the protein pectate lyase C reveal fast-forming intermediates and slow proline isomerizationDouglas E Kamen, Robert W Woody
Biochemistry|April 3, 2002
Identification of proline residues responsible for the slow folding kinetics in pectate lyase C by mutagenesisDouglas E Kamen, Robert W Woody
Journal of Virology|April 29, 2005
Structural basis for the physiological temperature dependence of the association of VP16 with the cytoplasmic tail of herpes simplex virus glycoprotein HDouglas E Kamen, Sarah T Gross, Mark E Girvin, et al.
Journal of Biomolecular NMR|February 15, 2008
GFT projection NMR based resonance assignment of membrane proteins: application to subunit C of E. coli F(1)F (0) ATP synthase in LPPG micellesQi Zhang, Hanudatta S Atreya, Douglas E Kamen, et al.
Journal of Pharmaceutical Sciences|August 29, 2023
Evaluation of the In-Use Stability of Monoclonal Antibody IV Admixtures Prepared from Drug Products Containing Polysorbate 20 Degraded by Host-Cell LipasesCaterina Riccardi, Dane P Carlson, Kenneth S Graham, et al.
Biophysical Journal|February 5, 2022
Low pK<sub>a</sub> of Lys promotes glycation at one complementarity-determining region of a bispecific antibodyXiaobin Xu, Jessica Ann O'Callaghan, Zachary Guarnero, et al.
Journal of Pharmaceutical Sciences|November 28, 2022
An Intercompany Perspective on Practical Experiences of Predicting, Optimizing and Analyzing High Concentration Biologic Therapeutic FormulationsPreeti G Desai, Patrick Garidel, Francisca O Gbormittah, et al.
Mabs|August 11, 2025
The nonglycosylated variant in therapeutic monoclonal antibodies preferentially forms large aggregates under typical thermal stresses used in forced degradation studiesGao-Yuan Liu, Jenny Kim Kim, Shuli Tang, et al.
Journal of Pharmaceutical Sciences|October 3, 2021
An Intercompany Perspective on Compatibility and In-use Stability Studies to Enable Administration Of Biopharmaceutical Drug ProductsDouglas E Kamen, George Crotts, Chakravarthy Narasimhan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemistry|April 3, 2002
Folding kinetics of the protein pectate lyase C reveal fast-forming intermediates and slow proline isomerizationDouglas E Kamen, Robert W Woody
Biochemistry|April 3, 2002
Identification of proline residues responsible for the slow folding kinetics in pectate lyase C by mutagenesisDouglas E Kamen, Robert W Woody
Journal of Virology|April 29, 2005
Structural basis for the physiological temperature dependence of the association of VP16 with the cytoplasmic tail of herpes simplex virus glycoprotein HDouglas E Kamen, Sarah T Gross, Mark E Girvin, et al.
Journal of Biomolecular NMR|February 15, 2008
GFT projection NMR based resonance assignment of membrane proteins: application to subunit C of E. coli F(1)F (0) ATP synthase in LPPG micellesQi Zhang, Hanudatta S Atreya, Douglas E Kamen, et al.
Journal of Pharmaceutical Sciences|August 29, 2023
Evaluation of the In-Use Stability of Monoclonal Antibody IV Admixtures Prepared from Drug Products Containing Polysorbate 20 Degraded by Host-Cell LipasesCaterina Riccardi, Dane P Carlson, Kenneth S Graham, et al.
Biophysical Journal|February 5, 2022
Low pK<sub>a</sub> of Lys promotes glycation at one complementarity-determining region of a bispecific antibodyXiaobin Xu, Jessica Ann O'Callaghan, Zachary Guarnero, et al.
Journal of Pharmaceutical Sciences|November 28, 2022
An Intercompany Perspective on Practical Experiences of Predicting, Optimizing and Analyzing High Concentration Biologic Therapeutic FormulationsPreeti G Desai, Patrick Garidel, Francisca O Gbormittah, et al.
Mabs|August 11, 2025
The nonglycosylated variant in therapeutic monoclonal antibodies preferentially forms large aggregates under typical thermal stresses used in forced degradation studiesGao-Yuan Liu, Jenny Kim Kim, Shuli Tang, et al.
Journal of Pharmaceutical Sciences|October 3, 2021
An Intercompany Perspective on Compatibility and In-use Stability Studies to Enable Administration Of Biopharmaceutical Drug ProductsDouglas E Kamen, George Crotts, Chakravarthy Narasimhan, et al.
Pageof 1